Bellevue Healthcare Franchise
BB Pureos Bioventures is advised by Bellevue Asset Management AG, a Swiss asset manager with a very strong and longstanding history in biotech investing. Since 1993, Bellevue manages BB Biotech AG, an investment company with focus on publicly listed mid-to-large size biopharmaceutical companies. Since then, Bellevue’s sector investment expertise grew substantially and today encompasses a broad range of healthcare investment topics with a number of different vehicles. Through BB Biotech, Bellevue completed its first venture investment in 1995, and co-launched its first healthcare venture capital fund (BB Bioventures I) in 1997. Since then, Bellevue backed over 80 private healthcare companies.